The central benzodiazepine site is an integral part of the gamma-aminobutyric acid (GABA) supramolecular receptor complex that plays a regulatory role on GAB A mediated neurotransmission (Schoch et al., 1985; Haefely, 1985a,b) , Most GABA neurotransmission stud ies in vivo in the human brain have been performed using positron emission tomography (PET) and e ' C]flumaze nil (FMZ), an antagonist of the benzodiazepine recep tors. Various quantitative methods have been developed with PET to measure the density (B I max) and affinity (Kd) of the benzodiazepine receptors (Pappata et al., 1988; Persson et aI. , 1989; Abadie et aI., 1992; Lassen et aI., 1995; . However, the main drawbacks of these quantitative methods are the rela tively long durations required and the complexity of ex periments, which require several injections of radioli-gands at different specific actIvitIes and the use of an arterial catheter for blood sampling. In addition to these quantitative methods, indirect approaches based on sim plified models have been developed to calculate indices of B ' max' such as the distribution volume (DV) or bind ing potential (BP) (Mintun et aI., 1984; Koeppe et aI., 1991 ) .
Single photon emission tomography (SPECT), which can also map the benzodiazepine receptors using [ 12 3 I]io_ mazeni1, is considered less accurate than PET at provid ing absolute measures of biologic parameters. Only a few quantitative studies (mainly in primates) to measure B ' max have been performed using this technique (Zoghbi et aI., 1992; Laruelle et aI., 1993 Laruelle et aI., , 1994a . For the hu man brain, SPECT studies have used indirect approaches to access information on receptor density (Laruelle et aI., 1994a,b ; Abi-Dargham et aI., 1994 .
Because SPECT is more readily available in clinical settings and is less expensive than PET, it would be helpful to determine the accuracy and the robustness of binding parameters estimated from SPECT data. Further more, SPECT protocols usually are simplified for routine clinical use, and binding parameters thus derived should be validated through comparison with PET data. In this regard, Westera et al. (1996) studied the DV for specific binding (DVJ from PET and SPECT data in the same subjects and found a good correlation between DV s PE T and DV S S P E C T values (r = 0.76 ). However, they did not compare measurements of DV, with absolute measures of B ' max' This issue is important because deriving accu rate receptor binding information from the DV depends largely on the pharmacokinetic properties of the tracer (Koeppe et aI., 1991) .
Another issue concerns the robustness of estimating SPECT binding parameters from the high noise level of SPECT data. To overcome this problem, large regions of interest (ROIs) have been used to estimate the binding parameters (Laruelle et aI., 1994b; Abi-Dargham et aI., 1994 Bremner et aI., 2000) , but parametric imag ing studies for SPECT data, in which high noise levels can be critical, have not been developed.
The current study set out to measure PET and SPECT binding parameters, BP and DV, in the same subjects and to determine if these parameters accurately reproduce the absolute values of B ' max' Furthermore, the authors inves tigated how these parameters allow for a robust pixel by-pixel implementation, yielding images of binding pa rameters for analysis.
MATERIALS AND METHODS

Subjects
Seven normal subjects, aged 23 to 36 years (mean 27.4 ± 5.6), participated in the current study. Positron emission to mography and SPECT experiments were performed on all sub· jects within 2 to 3 months. All subjects gave informed consent J Cereh Blood Flow Merah. Vol. 20. No. 1/, 2000 before scanning. The study was performed with the approval of the Research Ethics Committee of Geneva HospitaL
Positron emission tomography experiments
The subject's head was positioned in a head holder so that transaxial slices were obtained parallel to the orbito-meatal line, Scan acquisitions were performed on a whole body scan ner (ADVANCE, GE Medical System, Waukeska, WI, U,S,A,), The transaxial images of the brain were reconstructed using a filtered back-projection (128 x 128 matrix, 35 slices, 2.34 x 2,34 x 4.25 mm3 voxel size), Photon attenuation was corrected with a lO-minute transmission scan and data were corrected for decay.
Positron emission tomography scanning experiments were performed using a three-injection protocol (tracer injection; un labeled FMZ injection; coinjection of labeled and unlabeled FMZ) (Fig, I A) . An injection of ap proximately 4 mCi [ " ClFMZ was given intravenously at the scan start time, At 30 minutes, an intravenous injection of 0,0 I mg/kg of unlabeled ligand was administered (displacement in jection), At 60 minutes, a mixture of labeled (4 mCi) and un labeled flumazenil (0,02 mg/kg) was injected (coinjection). All injections were administered over a I-minute period using an infusion pump, Details of injected doses and specific activities are listed in Table I . A set of 48 sequential PET scans was obtained over 104 minutes according to the following protocol: 2 x 0.5 minutes; lOx I minute; 2 x 2 minutes; 3 x 5 minutes; lOx I minute; 2 x 5 minutes; I x 10 minutes; 4 x 0.5 minutes; 7 x I minutes; 7 x 5 minutes,
Single photon emission computed tomography experiments
Scan acquisitions were performed using a Toshiba GCA-9300A/HG triple-headed SPECT system in continuous rotation mode, using a super-high-resolution fan beam (SHR-FB) col limator (Kouris et al., 1993; Mahmood et al., 1994) . The to mographic spatial resolution at the center, with 132 mm radius of rotation, is 7,8 mm at full width at half maximum (FWHM) with the SHR-FB collimator. Three energy windows were de fined, one for the photopeak (159 ke V ± 20%) and two for scatter correction (159 ke V ± 7%). Data were reconstructed by filtered back-projection (Shepp and Logan filter) after the raw data were corrected by the triple-energy window method of scatter correction and the Chang filtered method of attenuation correction, Attenuation correction was performed, assuming a uniform attenuation equal to that of water (attenuation coeffi cient !-L = 0, ISO cm2/g) within an ellipse drawn around the transaxial plane. Images were displayed on a 128 x 128 x 46 matrix, The activity in cpm/pixel was then expressed in !-LCi/ pixel using a calibration factor of 0,00095 !-LCi/cpm obtained with phantom experiments performed at regular intervals. The phantom was an 1231 distributed source (50 MBq) of a 6-cm diameter acquired for 15 minutes and reconstructed with the same protocol used in the current study, The average cpm/pixel was measured in a large ROI positioned in the phantom image (Abi-Dargham et aL, 1995) . One sample (I mL) of the phantom solution was measured with the gamma-counting system to determine the calibration factor between SPECT and gamma counting system measurements, Single photon emission computed tomography data were ac quired using a single injection protocol (Fig, lB) , Approxi mately 3 mCi r'23Iliomazenil was intravenously injected as a single bolus over I minute. Details of injected doses and spe cific activities are listed in Table I frames was collected during 170 minutes according to the fol lowing protocol: 5 x 2 minutes; 10 x 5 minutes; 10 x II minutes.
Arterial plasma analysis
For the PET and SPECT studies, a catheter was inserted into the radial artery under local anesthesia, after clinical control of satisfactory collateral circulation.
During PET acquisition, 57 arterial whole blood samples (3 mL each) were withdrawn from the radial artery at a rate of I sample every 15 seconds for the first 4 minutes after each injection of labeled FMZ, to progressively longer time intervals (30 seconds, I, 2, and 5 minutes). After rapid blood centrifu gation, the plasma IIC radioactivity was measured using a gamma counting system. Measurements (in cpm/mL) were transformed into f.LCiimL using a calibration factor estimated before each experiment with a calibrated phantom (50 MBq) acquired and reconstructed using the same PET protocol. The plasma time-activity curves were then corrected for physical decay of IIC activity, and the plasma radioactivity concentra tions were transformed in FMZ time-concentration curves, us ing the corresponding specific radioactivity of C I ClFMZ. Thirty blood samples were analyzed for [I I Clflumazenil me tabolites after extraction using chloroform separation (De bruyne et aI., 1991; Barre et aI., 1991; . After each injection of [II C1FMZ, the rate of metabolite mea surements was one measurement every 30 seconds during the first 3 minutes, at 6, 8, 10, 15, and 20 minutes, then every 10 minutes. The percentage of unmetabolized [IIClFMZ in plasma was calculated from these measurements using a The doses 1i* and 1i correspond respectively to labeled and unlabeled ligand doses injected during the ith injection. PET, positron emission tomography; SPECT, single photon emission computed tomography.
t Specific activity at the first injection time. monoexponential curve, P nrn(t) = A+( lOO-A)e-Bt, where t is the time expressed in minutes. The metabolite-corrected arterial plasma curve was calculated using P nrn(t) ( Fig. 1 C) .
During SPECT acquisition, 33 arterial whole blood samples (3 mL each) were withdrawn from the radial artery, at the same rate of I sample every IS seconds for the first 3 minutes, to progressively longer time intervals (30 seconds, 1, 2, and 5 minutes).
Twenty-four blood samples were analyzed for [' 2 3Iliomaze nil metabolites using the same procedure as described above. The radioactivity in the chloroform layer represented the amount of remaining unmetabolized plasma iomazenil: Cart) . Metabolite measurements were per formed on all samples during the first 10 minutes and approxi mately every 5 minutes until the end of the experiment. The free fraction (Ca(t» was fitted to a sum of three exponentials ( Fig. lD) .
Image processing
For anatomic localization of the cortical structures, a TI weighted MR brain image volume was obtained for each sub ject (PICKER Eclipse 1.5T; TR = 15 milliseconds; TE = 4 milliseconds; pixel size: 0.98 x 0.98 x l. l0 mm3). For realign ment, PET frames 16 and 17 and SPECT frames 23 and 24 were averaged to produce mean PET and SPECT images, re spectively, to provide satisfactory whole-brain anatomic defi nition. Each subject's MRI and the mean SPECT image were aligned to the mean PET image, using the Automated Image Registration software (AIR v3.08) (Woods et a!., 1992 (Woods et a!., , 1993 using a six-rigid-body algorithm. The resulting transformation matrix of the mean SPECT image was applied to the dynamic SPECT images to realign SPECT frames to the mean PET images (Fig. 2) .
Data analysis
Twenty-seven circular ROIs (r = 7.02 mm) were used to obtain PET and SPECT time-concentration curves from struc tures identified on the MR images by visual inspection. Then these ROIs were applied to the dynamic PET and SPECT im ages. Twenty-two ROIs were placed on the left and right hemi spheres for cerebellum, lateral frontal cortex, somatosensory cortex (SMC), posterior parietal cortex, inferior and superior temporal cortex, hippocampus, amygdala, caudate, putamen, and thalamus. Five ROIs were placed on pons, median frontal cortex, median parietal cortex, anterior cingulate, and occipital cortex.
The authors used four different methods (A, B, C, and D) to estimate the benzodiazepine receptor-binding parameters. A complete description is presented in Appendices A to D and is summarized in Table 2 . In Method A, a three-compartment model, the metabolite-corrected arterial plasma curve, and the metabolite-uncorrected whole blood curve were used to fit PET data acquired with the multiinjection protocol ( Fig. lA) , 1995) . The BP and the total (DV T) and specific (DV s) distribution volumes were calculated from the estimated parameters B' max' k " k 2 ' konN R ' koff (Appendix A). This first fitting strategy can only be applied to dynamic PET data be cause the three-injection protocol allows one to estimate all model parameters. These binding parameter estimations were used as reference values to study indices of receptor density using PET and SPECT data. In Method B, unconstrained and constrained three-compartment models were used to estimate BP, DV T' DV s, and BP c (DVf+ns = 3.2) (Abi-Dargham et a!., 1995) from SPECT data corresponding to the single-injection protocol (Appendix B). In Method C, a two-compartment model was used to calculate DV /' = k/kz" from SPECT and PET data acquired after the first labeled injection (Koeppe et a!., 1991) (Appendix C, Fig. lA and B ). In Method D (Appen dix D), delayed-activity (DA) images were calculated from averaged PET (16, 17) and SPECT (23, 24) frames, corre sponding to a duration of 10 and 20 minutes, respectively.
For each model configuration, parameters were identified by minimization of a weighted least-squares cost function, using Marquardt'S algorithm (Marquardt, 1963) . The authors used a weight defined by Wi = (tj-tj_,)/y(t), where yet) corresponds to the PET or SPECT measure at time t;. This is a reasonable choice in experiments involving radioactivity counts (Mazoyer et aI., 1986) .
Parametric images
Parametric images were obtained using model estimates cal culated from filtered pixel-by-pixel kinetic curves. The authors used a temporal filter based on the wavelet transform that al lows one to conserve the original spatial resolution of PET and SPECT images (Millet et aI., 2000) . The wavelet analysis pro cedure was performed using the discrete wavelet transform and a Daubechies filter of order 10 (number of coefficients = 20) (Daubechies, 1989) . When applying this filter, the pixel-by pixel PET and SPECT kinetic data are decomposed to their essential components, namely the detail signals and its approxi mation. The original signal can be recovered by summing the approximation and all the detail signals (Castleman, 1996; Mal-lat, 1998) . However, before reconstruction, some of the detail signal can be shrunk to a particular threshold without substan tially affecting the main features of the data set. Therefore, the authors applied a threshold of the detail signals, using statistical criteria described by Millet et al. (2000) . The shrunken signals were then transformed back to the domain of the original data to obtain a time-frequency-filtered signal.
The filtered PET and SPECT pixel-by-pixel kinetic curves were used to estimate model parameters. The resulting estimate sets were used to build parametric images at the pixel level.
RESULTS
Positron emission tomography hinding parameters
Average ROI values from seven subjects are described in Table 3 and Figs. 3 to 5. Results of the PET correlation analysis for each subject are shown in Table 4 . 
Values represent the mean, standard deviation (SD), and coefficient of variation (% COY) from seven subjects. PET, positron emission tomography; BP, binding potential; DV, distribution volume; ctx, cortex; LR, average of left and right hemispheres.
Five parameters (B' m a x' kto k2, k on/V R' k o ff) were es timated using Method A. The ranges of values for all model parameters were in accordance with those pub lished elsewhere (Price et aI., 1991 (Price et aI., , 1993 Lassen et aI., 1995; Delforge et aI., 1995) . Figure 3 shows the main correlations between model parameters as a linear cor relation between receptor density (B' m a x) and ligand affinity (Fig. 3A) , and the k/k2 ratio versus B' m a x values (Fig. 3B) . The authors found a weak correlation between k]/k2 and B' m a x values, and coefficients of cor-relation from individuals ranged from 0.024 to 0.595 ( Table 4) .
High correlations were found between BP p ET and B ' m a x values (r > 0.900) and between DV S PET and B' m a x values (r > 0.906; Table 4 ). The distribution volume values were similar with a two-compartment model (Method C) and a three-compartment model (Method A) as previously reported (Koeppe et aI., 1991) . The corre lation coefficient across all regions for the seven subjects is r = 0.99 7 (DVT " p ET = -0.082 + 0.989 DVT PET)' Therefore, the authors used only DV / PET values for fur ther analysis in the current study. The relation between DV/PET and Bf ma x values was analyzed using a simple linear regression fit and a nonlinear univariate regression, fitting equation A 7 to DV/'PErBf max data (Fig. 4). [n the latter case, equation
A7 can be expressed as follows: DVT PET = (C 3 + C4Bf max [ l + Bf maJ( C] + C2Bf max)]), where coefficients C], C 2 , C 3 , C4 were replaced by C] = 3.75 , C 2 = 0.161 (Fig. 3A) , C 3 = 0.73, C4 = 0.00 15 (Fig. 3B) . Using a simple linear regression, the coefficient of correlation was r = 0.954. With the nonlinear relation, the coeffi cients of correlations were r = 0.967 and r = 0.942 in fixing the k/k 2 ratio to a constant value (C4 = 0). In all experiments, the C4 coefficients were weak (Table 4) , but the quality of the fit was significantly improved using a C4 value different from zero. In fitting equation A 7 to data from all subjects (not shown) using a direct least squares method, the coefficient correlation was slightly improved (r = 0.978).
Relation between PET delayed activity and distribution volume
Positron emission delayed activity (DApET) was cor related with DVT "PET as shown in Fig. 5 (r = 0.992).
For individuals, there was an excellent correlation be tween the two parameters, with coefficients of correla tion ranging from r = 0.975 to 0.999 ( Table 4 ) . In the current study, the intercept value that corresponds to AFvCa(t) (Appendix D l ) was negative ( Fig. 5) . A partial volume effect could underestimate the delayed activity of the small ROIs with low-receptor density and modify the slope, and thus the intercept of the regression line. The ROIs with less activity were the hippocampus, amygdala, caudate on the left and right hemispheres, and pons (Fig. 5) .
Correlation between distribution volumes (DV"PET) and DApET calculated versus acquisition times (frames from the beginning of the experiment to 30 minutes after the first injection) led to coefficients of correlation close to unity (r '" I ) with data acquired 17 minutes from the start of the scan.
Estimation of model parameters from SPECT data
Average ROI values from seven subjects are described in Table 5 and Figs. 6 to 8. Results of the PET and SPECT correlation analysis for each subject are shown in Table 6 .
Single photon emission computed tomography data were analyzed using an unconstrained three-compart ment model, described in Appendix B. The BPSPECT' DV T SPEeT' and DV S SPECT values were calculated with the four estimated parameters. As previously reported (La-melle et aI., 1994b; Abi-Dargham et aI., 1994 , the authors encountered many convergence problems during the identification procedure because of difficulties in es timating k 3 and k 4 parameters. These parameters were identified with aberrant relative standard errors greater than 100%, especially in poor receptor regions with a low signal-to-noise ratio. Consequently, BPSPECT' DV T SPECT , and DV S SPECT values had large relative standard errors.
For the above reasons, the authors used a constrained three-compartment model (k/k2 = 3.2) to estimate DVT SPECT and BPSPECT (DVTC SPECT and BPc SPECT' respec tively). With this constrained model, the standard errors for k3 and k 4 parameters are smaller, thus a better esti mation of DV TC SPECT and BP C SPECT parameters exists, particularly in poor receptor regions such as the pons ( Table 5) .
DVT "s PECT and DVT SPEcr values were strongly cor related (r = 0.999), with a bias for high DVT values ( Fig. 6) . Individual correlation coefficients ranged from 0.988 to 0.999 with slopes ranging from 0.964 to 1.1 and intercepts ranging from -0 .0 8 to 1. 93 ( Table 6) .
Relation between SPECT delayed activity and distribution volume Figure 7 shows a high correlation between DV/'SPECT and DA sPECT values calculated from Methods C and D, respectively. For the seven subjects, this correlation ranges from r = 0.952 to r = 0.9 79 ( Table 6 ). Coeffi
cients of correlation between DV /' SPECT and DA sPECT
show an optimal value of r '" 0.960, within 90 to 160 minutes. Activity values of subcortical ROls were un derestimated compared with those obtained in cortical ROls. This underestimation might be explained by the partial volume effect due to the limited spatial resolution of SPECT or by the weak sensitivity of SPECT. DV /' SPECT and B ' max' despite a bias for DV /' SPECT pa rameters ( Table 6 ; Fig. 8A ). Figure 8B between BPSPECT and B
' max values was mainly because of convergence problems of the k4 parameter. Table 6 shows variable individual correlation between these two parameters, with a range of coefficients from r = 0.436 to r = 0.708. The best correlation between indices and B ' max values was found for BPc SPECT (r = 0.914), fol Figure 9 shows how PET and SPECT binding param eters can be used for a pixel-by-pixel implementation using a wavelet filtering method (Millet et aI., 2000) , leading to parametric maps of the entire brain. The B ' max and Kd V R images correspond to the estimated param eters, whereas DV and BP images were calculated from those estimated parameters. The BPpET and DV S PET im ages were visually similar to the B ' max image in most cortical structures. In low-receptor regions and white matter, the BPPET values were slightly higher. The DVT PE T and DV /' PET images were close to the DApET map, as shown in Fig. 5 . For SPECT studies, DV TC SPECT' BP C SPEC T, DV/'SPECT, and DA sPE CT parametric images ap peared very similar, as previously described in Figs. 6 to 8. The convergence problems during estimation that were encountered with ROI analysis were confirmed and increased with parametric images at the pixel level (see BP sPE cr, aberrant values in red and white). The DV S SPEC T and DV T SPECT images, calculated with equations B6 and B8, respectively, have not been obtained with correct standard errors.
In Fig. 1 0, B ' max parametric images obtained in one normal subject are directly compared with the delayed activity maps using PET and SPECT data. These images show obvious similarities, despite the poorer resolution of SPECT images.
DISCUSSION
The current study focused on the possibility of extract ing binding information from SPECT data. Several stud ies have demonstrated the usefulness of indices such as BP or DV to measure receptor density (Laruelle et aI., 1994b; Abi-Dargham et aI., 1994 . However, whereas the methodology for studying ligand-receptor interactions has been widely developed with various ra dioligands, only one study has correlated binding param eters estimated from PET and SPECT data (Westera et aI., 1996) . Furthermore, the binding parameters studied corresponded only to DV and BP indices of receptor concentration (B' max) . No studies have directly com pared the relations between B ' max and indices of binding parameters estimated using simplified methods. A com parison between indices of binding parameters and an absolute value, the receptor concentration, seems appro priate to evaluate the efficiency and robustness of these parameters. The analysis of PET and SPECT data in this article is based on the search for a simplified method, giv ing such robust information about receptor density. Many studies have been performed using ROIs to determine FIG. 9. Pixel-by-pixel parametric images of binding parameters estimated from positron emission tomography (PET) and single photon emission computed tomography (SPECT) data corresponding to a slice of one normal subject brain. Anatomic magnetic resonance imaging (MRI) corresponds to the same PET and SPECT slices. This tomographic slice passes through the basal ganglia, thalamus, and frontal, temporal, and occipital cortices. B ' ma x and kdVR parameters correspond to absolute values estimated from PET data with the multiinjection protocol. Binding potential (BP, BPcl, total and specific distribution volumes (OVT' OVs), and delayed activity (OA) corre spond to indices of receptor concentration. Each image has been rescaled to its own maximum.
which may be the best strategy to fit the data; thus, statistical tests to compare different model configura tions have been widely developed (Laruelle et ai., 1994b; Abi-Dargham et ai., 1994 Buck et ai. , 1996) . The current study was primarily restricted to the analysis of correlation between indices used in clinical routine and the B I max parameter. Furthermore, the authors ' analysis allowed them to determine the robustness of these indi-ces when they are used to build parametric images at the pixel level, where noise levels of dynamic data are greater than those encountered using large ROIs.
In the current study, the multiinjection approach was used to estimate quantitative values of binding param eters (B I max' Kd V R) from e I C]FMZ data. This method, used with various radioligands, was efficient in identify ing receptor concentration and ligand affinity with a single experiment, without restriction on model param eters (Delforge et aI., 1995) . The B' max values estimated in the current study were in concordance with those pub lished previously (Price et aI., 1991 (Price et aI., , 1993 Lassen et aI., 1995; Delforge et aI., 1995) .
The first part of this article was devoted to clarify relations between B' max and indices of receptor concen tration using only PET data. The authors have shown, using such data, that the distribution volume (DV/'PET) estimated using a two-compartment model and a single injection protocol was a good index of receptor density in the context of ligand-receptor interaction using e ' C]flumazeniI. Furthermore, the distribution volume (DV) values estimated using a two-(DV /'PET) and three (DV T PET) compartment model are highly correlated. This result is explained by the rapid equilibrium of ra dioligand between tissue compartments after [ " C]FMZ injection. Thus, the DV/'PET parameter can be described by a combination of parameters from a three-compart ment model (Eq. A7). As Koeppe et aI. (199 1) and single photon emission computed tomography (SPEeT) data. S'max pa rameter is estimated with the multiin jection approach, whereas PET and SPEeT images are calculated from averaged PET (16, 17) and SPEeT (23, 24) frames corresponding to a du ration of 10 and 20 minutes, respec tively. Images represent 4 matching transaxial levels selected from sets of 35 simultaneously scanned planes. The images show the distinction be tween areas of highest benzodiazepine receptor numbers within the cerebral cortex and regions of fewer benzodi azepine receptors, including the thalamus, basal ganglia, cerebellar cortex, and the pons.
The first result, shown in Fig. 3A , is the linear relation between B' max and Kd V R parameters, widely described for in vivo measurements by several authors (Millet et aI., 1995; Delforge et aI., 1995) . This linear relation de rives from the V R term, defined as the 'reaction volume," and introduced by Delforge et aI. (1996) to account for the heterogeneity of the free ligand concentration. There fore, the equilibrium dissociation rate constant estimated by PET data corresponds to Kd V R and not kd alone. Furthermore, this relation has been recently confirmed in the human brain with in vitro studies (Nagy et aI., 1999) .
The second result concerns the correlation between the B' max and k/k' 2 ratio shown in Fig. 3B . For several authors, this ratio is independent of B' max values. How ever, attempts to fix the k,!k' 2 ratio to a constant value to improve parameter estimates produce larger B' max values (Price et aI., 1993) . The authors found a correlation be tween the B' max and k 1 !k' 2 ratio, suggesting that these two parameters are not totally independent. Neverthe less, the simplification of the model by combining the free and nonspecific compartments in a single compart ment concerns the k' 2 parameters (Appendix A). This simplification, valid with rapid equilibrium condition be tween free and nonspecific compartments, may not be justified in poor receptor regions (Koeppe et aI., 1991) . However, this problem with the k,!k 2 ' ratio does not perturb the correlation between DV/' PET and B ' max as shown in Fig. 4 , and this relation can be easily approxi mated, in this instance to a linear relation (r = 0.954).
Using SPECT data, the DV T and BP values calculated differed by a constant value from published results (Abi Dargham et aI., 1994 . This difference was essen tially because of the method used to access input func tion, in particular, the free fraction (f l ) of unmetabolized iomazenil not bound to protein (Westera et aI., 1996) . However, the method used to determine [ 1 23 I]Iomazenil arterial plasma activity did not influence coefficients of correlation results.
Using SPECT data, the authors used two-and three compartment models to estimate binding parameters. The unconstrained three-compartment model led to seri ous convergence problems during the estimation proce dure. The difficulty in estimating four parameters cor rectly from a three-compartment model with SPECT data, using a single injection protocol, has been reported frequently in the literature (Laruelle et aI., 1994b; Abi Dargham et aI., 1994 . Therefore, several authors proposed that this model should be simplified by con straining the k/k2 ratio to a constant value (Laruelle et a!., 1994b; Abi-Dargham et aI., 1994 . This sim plification, when applied to the current data, canceled the convergence problems and improved standard errors on parameter estimates. The use of a two-compartment model to fit SPECT data produced a slight bias on DV T values, which can be explained by the longer time needed for equilibration of [ 1 23 I]iomazenil between the tissue compartments. Although better fits were obtained with a three-compartment model (Abi-Dargham et a!., 1995; Buck et aI., 1996; Bremner et aI., 2000) , the au thors showed a strong correlation, close to unity, be tween DVT SPECT and DV/'SPECT values, and no diver gence problems were noted during the fitting process using a two-compartment model.
The similarity between SPECT binding indices and the B ' max parameter suggests that the DV /' SPECT param eter, estimated with a two-compartment model, is a ro bust method to access receptor density information. The authors showed that it is impossible to build correct para metric maps using an unconstrained three-compartment model because of divergence problems. The use of con strained three-compartment and two-compartment mod els led to similar maps of binding parameters. As shown with the correlation analysis, the authors did not observe significant differences between these images. In contrast to the usual SPECT studies (Laruelle et aI., 1994a,b; Abi-Dargham et aI., 1994 , the current SPECT data have been obtained with only 4 mCi [ 1 23 I]iomazenil. This recommended low dose (Verhoeff et aI., 1993) can lead to low signal-to-noise ratios in dynamic data, and thus will tend to increase divergence problems during the estimation procedure. For example, the BPSPECT param-eter is nonidentifiable with the current SPECT data using an unconstrained three-compartment model, because of difficulties in identifying k 3 and k4 parameters with ac ceptable standard errors . The unconstrained three compartment model can be used to analyze SPECT data with a high signal-to-noise ratio, but becomes unreliable with noisy data obtained using SPECT. This noise prob lem is important because it is a limiting factor in para metric imaging. With the wavelet filtering, the authors were able to build PET and SPECT parametric images at the pixel level (Millet et aI., 2000) . Parametric imaging has also clearly confirmed the results of correlations be tween these binding parameters. The authors observed large similarities between DV, BP, DA maps, and the B ' max images. The only difference can be noted in poor receptor regions, such as cerebellum, where the SPECT delayed activity values are larger than those in B ' max images. A possible explanation is that in the poor recep tor regions, the equilibrium state is reached later and the measured delayed activity can be overestimated (Frey et aI., 199 1) .
This work has focused on methods that can be used in clinical routines in which a compromise between accu racy and simplicity of the method used is important. Results of the comparison between delayed-activity and distribution volume values in PET and SPECT are es sential. Correlation coefficients are slightly different from unity (Figs. 5 and 7) . It is possible to gain access to information on receptor density directly with delayed activity images without measuring the input function (ar terial catheter) and without acquiring the whole set of kinetic data of the radioligand. Therefore, the long time needed for equilibration of [ l 23 Iliomazenil, as compared with that of [ ' I C]flumazenil, is not a restrictive problem because only 20 to 30 minutes of summed data are re quired, 90 minutes after injection. The delayed-activity index is a relative measure directly obtained from PET or SPECT data. However, it is possible to have an absolute index, for intersubject comparisons, by dividing PET or SPECT values by the specific activity and by the injected dose.
Moreover, these indices of benzodiazepine receptor density are independent of cerebral blood flow and glu cose metabolism changes. Indeed, it has been shown re cently (Meyer et aI., 1995; Ohyama et aI., 1999 ) that the receptor density and distribution volume values are nor mal in Alzheimer ' s disease patients, with a decrease of cerebral blood flow and glucose metabolism. APPENDIX A Figure Al shows a three-compartment model (unme tabolized FMZ in plasma, free and nonspecific ligand, and ligand bound to receptor sites) used to estimate five parameters (B'max , k], k ' 2 ' konNR, koff) with the multi injection approach (Syrota et aI., 1984; Delforge et aI., 1993) . The parameters k] and k' 2 are associated with the exchanges between the plasma and the free and nonspe cific ligand compartment. In the context of FMZ studies, the authors used a simplified configuration of the model that combines the free and nonspecific compartments in a single compartment (Goeders and Kuhar, 1985; Koeppe et aI., 1991) . Therefore, the k2 parameter is modified and can be expressed by the following expres sion: k' 2 = k2/(l +k S ik6), where ks and k6 correspond to the rate constants describing exchanges between nonspe cific and free compartments. B' max represents the con centration of receptors available for binding (effects of endogenous ligands are not included in model); kon and koff are the association and dissociation rate constants, respectively; and V R is the volume of reaction, which accounts for tissue inhomogeneity (Delforge et aI., 1996) . The kon and V R parameters cannot be estimated separately, and only the konN R ratio is identifiable. Con sequently, only the apparent equilibrium dissociation constant, Kd V R ' can be estimated. Kd is the equilibrium dissociation constant, defined as the ratio of koff to kon . The parameter FV represents the fraction of blood pre sent in the tissue volume and is assumed to be 0.05 in this study.
The multiinjection protocols include injection of un labeled ligand (with or without simultaneous labeled li gand injection). The kinetics of the unlabeled ligand afk ( , . ) fects the local concentration of free receptor sites and therefore must be taken into account. The unlabeled and labeled ligand kinetics are assumed to be similar. Thus, the model contains two components with the same struc ture and parameters. The plasma concentration of the unmetabolized unlabeled ligand was simulated from the curve corresponding to the labeled ligand. Parameter identification and simulations of labeled and unlabeled ligand kinetics were performed using the equation sys tem corresponding to the model diagram of Ligand kon and koff are the association and dissociation rate constants , respec tively; and VR is the volume of reaction, which accounts for tissue inhomogene ities. All ligand transfer probabilities be tween compartments are linear except for the binding probability, which de pends on the bimolecular association rate constant (kon), the local free ligand concentration (Mf(t)N R), and the local concentration of free receptor sites [B'max -Mb *(t)-Mb(t)]. The PET experimental data correspond to the sum of the labeled ligand in the free and bound ligand compartments and a fraction , F v' of the blood compartment.
In PET studies, experimental data [denoted by M¥(t l )] collected between times tj_ 1 and tj are given by the fol lowing integral relation: 
From the model parameters estimated, some binding pa rameters can be calculated (Mintun et aI., 1984; Koeppe et aI., 1991) :
(A6)
APPENDIX B Figure B 1 shows a three-compartment model used to analyze kinetics of [ 1 23 I]iomazenil in the brain. It in cludes the arterial plasma compartment concentration (Ca(t)); the nondisplaceable compartment concentration (Cf+ns(t)), which corresponds to the free, nonspecific compartment concentrations; and the specifically bound compartment concentration (Cs(t)). The tracer concentra tion over time in each compartment is given by: dCf +ns( t) , , dt = k I Ca(t) -k2Cf+ns(t) -k 3 Cf+ns(t) + k4Cs(t),
where kl and k/ parameters define rate constants (min-I ) for transfers across the bloodbrain barrier (BBB) (k2 ' = k2/(l + k S !k6)), and k 3 ' and k4 are rate constants (min-I ) for transfers between free and bound compartments (k 3 ' = k3/(l + k S !k6))· The ks and k6 parameters are the rate constants for transfers between the free and nonspecific single photon emission computed tomography time·concentra· tion curves obtained from a single'injection protocol. This is a simplified configuration combining free and nonspecific compart· ments. The rate constants, k5 and k6' associated with the ex· changes between free and nonspecific compartments are con· sidered rapid compared with blood-brain barrier (BBB) transport rates, k1 and k2. Thus, the k2' parameter is described by k; = k2/(1 +k5/k6) and k3' = ki(1 +k5/k6)· compartments. The total activity in a region of interest (CRm(t)) is described by:
where F v is the vascular fraction fixed to 5% in the current study. The equilibrium volume of distribution of a compart ment, i, relative to the free tracer (DVJ, was defined as the equilibrium ratio of the tracer concentration, Ci, to the free tracer concentration in the arterial plasma (Ca) (Mintun et aI., 1984) ,
Equilibrium distribution volumes can be calculated from model parameters using Eq. B4. Only definitions are given in this Appendix because the theory is widely de scribed in the literature (Laruelle et aI., 1994b; Abi Dargham et aI., 1994 . 
DVf +ns' DVs, and DVT are the nondisplaceable (free + nonspecific), specific, and total equilibrium distribution volumes, respectively, relative to the arterial tracer con centration. BP corresponds to the binding potential.
APPENDIX C Figure C 1 shows a two-compartment model used to analyze brain uptake of [ 11 C]FMZ and [ 1 23 1]iomazenil. This configuration has been proposed by to describe the kinetics of [ 1 1 C]FMZ , A single and SPEeT time·concentration curves obtained from a single· injection protocol. A single tissue compartment involving free, nonspecific, and specific compartments assumes that tissue compartments equilibrate rapidly with respect to blood-brain bar· rier (BBB) transport rates, tissue compartment that involves the three tissue com ponents: C/ = C f + Cns + Cs' can be used because of a rapid equilibrium state between all tissue compartments with [ I I C]FMZ data. The equilibrium volume of distri bution is given by:
where kl k ' I (C 1)
APPENDIX D
The distribution volume concept assumes that equilib rium is reached between the tissue compartments. In this case, using the model equations at the equilibrium state, the following relation is immediately obtained (Millet et aI., 1995): [ k] ( B :n ax kon )]
where DA(t) is the delayed activity, X. is a constant, and Ca(t) is the input function. The main interest of the ac tivity image approach is to avoid excessive blood sam pling.
